Teva Pharmaceutical Industries Limited (LON: 0LER)
London
· Delayed Price · Currency is GBP · Price in USD 22.12
+0.16 (0.73%)
At close: Jan 22, 2025
Teva Pharmaceutical Industries Revenue
Teva Pharmaceutical Industries had revenue of $4.33B USD in the quarter ending September 30, 2024, with 12.52% growth. This brings the company's revenue in the last twelve months to $16.77B, up 9.81% year-over-year. In the year 2023, Teva Pharmaceutical Industries had annual revenue of $15.85B with 6.17% growth.
Revenue (ttm)
$16.77B
Revenue Growth
+9.81%
P/S Ratio
n/a
Revenue / Employee
$459.86K
Employees
36,472
Market Cap
20.28B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 15.85B | 921.00M | 6.17% |
| Dec 31, 2022 | 14.93B | -953.00M | -6.00% |
| Dec 31, 2021 | 15.88B | -781.00M | -4.69% |
| Dec 31, 2020 | 16.66B | -228.00M | -1.35% |
| Dec 31, 2019 | 16.89B | -1.38B | -7.57% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 221.41B |
| AstraZeneca | 38.20B |
| HSBC Holdings | 43.25B |
| Unilever | 51.12B |
| Rio Tinto Group | 42.87B |
| RELX PLC | 9.30B |
| BP p.l.c. | 144.69B |
| British American Tobacco p.l.c. | 26.18B |